search
Back to results

Peripheral Nerve Injections for CRPS

Primary Purpose

Complex Regional Pain Syndromes

Status
Unknown status
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
Triamcinolone Acetonide 40mg/mL
Saline Injection
Sponsored by
Ottawa Hospital Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Complex Regional Pain Syndromes

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Able to provide signed and dated informed consent form
  2. Male or female, aged ≥18 years old
  3. Satisfy the Budapest Criteria for upper extremity CRPS
  4. A VAS score of at least 40 mm in the upper extremity to avoid flooring effect for injection-related pain reduction

Exclusion Criteria:

  1. Uncontrolled hypertension (>180/110)
  2. Sepsis
  3. Bleeding diathesis
  4. Active cancer
  5. Brachial plexus injuries
  6. Neurological language deficits precluding participation
  7. Mini mental state examination score < 23
  8. Acute mental illness (An acute mental illness is characterized by clinically significant symptoms of any metal health illness that requires immediate treatment. The physician making the recommendation to be part of the study. If the patient exhibits symptoms of any mental health illness that is not being treated by either the recommending physician or another member of the patient's care team the patient will not be recommended to participate in the study)
  9. Patients who are pregnant or breastfeeding

Sites / Locations

  • The Ottawa Hospital
  • Elisabeth Bruyere Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Treatment

Placebo

Arm Description

The intervention group will receive: Suprascapular nerve block - 3 mL of 0.5% Bupivacaine and 1 mL of 40 mg/mL Kenalog Median nerve block - 3.5 mL of 0.5% Bupivacaine and 0.5 mL of 40 mg/mL Kenalog Ulnar nerve block - 3.5 mL of 0.5% Bupivacaine and 0.5 mL of 40 mg/mL Kenalog

Placebo The placebo group will receive: Suprascapular nerve injection - 4 mL of normal saline Median nerve injection - 4 mL of normal saline Ulnar nerve injection - 4 mL of normal saline

Outcomes

Primary Outcome Measures

Recruitment
Number of participants who are successfully recruit into the study.
Randomization
Number of participants who accept being randomized into either the intervention or placebo treatment arms and receive the injection accordingly.
Blinding - Participant
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Blinding - Participant
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Blinding - Participant
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Blinding - Participant
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Blinding - Interventionist
The interventionist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Blinding - Physiotherapist
The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Blinding - Physiotherapist
The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Blinding - Physiotherapist
The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Retention
The percentage of participants who remained in the study for the entire duration of their planned involvement.
Data completion
The percentage of participants who complete all of the study questionnaires
Rate of Adverse events
We will track adverse events the participants experience

Secondary Outcome Measures

Pain - Visual Analog Scale
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Pain - Visual Analog Scale
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Pain - Visual Analog Scale
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Pain - Visual Analog Scale
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Pain - Visual Analog Scale
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Pain - Visual Analog Scale
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Pain - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Pain - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Pain - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Pain - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Pain - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Disease Severity - Complex Regional Pain Syndrome Severity Score
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Disease Severity - Complex Regional Pain Syndrome Severity Score
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Disease Severity - Complex Regional Pain Syndrome Severity Score
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Disease Severity - Complex Regional Pain Syndrome Severity Score
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Disease Severity - Complex Regional Pain Syndrome Severity Score
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Emotional and Psychological Function - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Emotional and Psychological Function - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Emotional and Psychological Function - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Emotional and Psychological Function - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Emotional and Psychological Function - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Quality of Life - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Quality of Life - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Quality of Life - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Quality of Life - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Quality of Life - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Total Score - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Total Score - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Total Score - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Total Score - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Total Score - EQ-5D-5L
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.

Full Information

First Posted
January 21, 2021
Last Updated
February 3, 2021
Sponsor
Ottawa Hospital Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT04744675
Brief Title
Peripheral Nerve Injections for CRPS
Official Title
Peripheral Nerve Injections for the Treatment of Upper Extremity Complex Regional Pain Syndrome: A Feasibility Study for a Proposed Randomized Design
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 2021 (Anticipated)
Primary Completion Date
October 2022 (Anticipated)
Study Completion Date
March 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ottawa Hospital Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background Complex regional pain syndrome (CRPS) is characterized by intense pain and loss of function, and associated with motor, trophic, sudomotor, and/or vasomotor changes of the affected extremity. CRPS of the upper extremity is seen frequently in our electrodiagnostic, neurology, and musculoskeletal clinics and occurs in up to one-third of patients who have undergone common surgical procedures, such as carpal tunnel release or release of Dupuytren's contracture. To date, there is a limited understanding of the underlying pathophysiology of CRPS. As a consequence, few effective treatment options are available. Peripheral nerve blocks have proven to be successful in reducing pain for several musculoskeletal and neurologic conditions. These blocks could be an opportunity for blocking somatic and autonomic sensory fibers that are thought to contribute to CRPS. In a small exploratory study, we found that peripheral nerve blocks in the upper extremity (suprascapular and median nerves) resulted in a 56% and 37% pain reduction in the shoulder and hand two weeks after injection, respectively, and were well-tolerated in patients with CRPS. While this was highly encouraging, large randomized placebo-controlled trials (RCTs) are necessary to demonstrate effectiveness and safety of nerve blocks for this population before this treatment is accepted into clinical practice. This proposal aims to demonstrate the feasibility of performing such a RCT. Objective To evaluate the feasibility of performing a placebo-controlled RCT assessing the efficacy and safety of peripheral nerve blocks (suprascapular, median, and ulnar nerves) for reducing pain in patients with CRPS. This is a phase IV feasibility study that will test the critical elements necessary for performing a RCT. Methods We will recruit participants (≥18 years old) from The Ottawa Hospital, Bruyère Continuing Care (Elisabeth Bruyère Hospital, St-Vincent Hospital), and Providence Care Hospital (Kingston, ON), meeting the well-established clinical Budapest criteria for upper extremity CRPS and having a visual analog scale (VAS) pain score of at least 40 mm (to avoid flooring effect). Participants will be block-randomized by the Ottawa Methods Centre to receive injections of either A) intervention (suprascapular, median, and ulnar nerves) with bupivacaine and triamcinolone acetonide, or B) placebo (saline). All participants will receive standard care for CRPS. Feasibility outcomes will focus on crucial methodologic aspects for the future RCT, including: (1) level of recruitment, (2) rate of acceptance from eligible patients to the randomization procedure, (3) blinding efficacy, (4) degree of patient retention, (5) rate of data completion, and (6) rate of adverse events for both the placebo and intervention groups. Outcome measures will be evaluated within 1 hour, 2 weeks, 6 weeks, and 3 months post-injection.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Complex Regional Pain Syndromes

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Arm Description
The intervention group will receive: Suprascapular nerve block - 3 mL of 0.5% Bupivacaine and 1 mL of 40 mg/mL Kenalog Median nerve block - 3.5 mL of 0.5% Bupivacaine and 0.5 mL of 40 mg/mL Kenalog Ulnar nerve block - 3.5 mL of 0.5% Bupivacaine and 0.5 mL of 40 mg/mL Kenalog
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo The placebo group will receive: Suprascapular nerve injection - 4 mL of normal saline Median nerve injection - 4 mL of normal saline Ulnar nerve injection - 4 mL of normal saline
Intervention Type
Drug
Intervention Name(s)
Triamcinolone Acetonide 40mg/mL
Other Intervention Name(s)
Kenalog
Intervention Description
Triamcinolone acetonide is a synthetic glucocorticoid corticosteroid with marked anti-inflammatory action, in a sterile aqueous suspension suitable for intramuscular, intra-articular, and intrabursal injection.
Intervention Type
Drug
Intervention Name(s)
Saline Injection
Intervention Description
Saline is a buffer solution commonly used in biological research. It is a water-based salt solution containing disodium hydrogen phosphate, sodium chloride and, in some formulations, potassium chloride and potassium dihydrogen phosphate. The buffer helps to maintain a constant pH. The osmolarity and ion concentrations of the solutions match those of the human body.
Primary Outcome Measure Information:
Title
Recruitment
Description
Number of participants who are successfully recruit into the study.
Time Frame
Week -2
Title
Randomization
Description
Number of participants who accept being randomized into either the intervention or placebo treatment arms and receive the injection accordingly.
Time Frame
Week 0
Title
Blinding - Participant
Description
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 0
Title
Blinding - Participant
Description
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 2
Title
Blinding - Participant
Description
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 6
Title
Blinding - Participant
Description
The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 12
Title
Blinding - Interventionist
Description
The interventionist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 0
Title
Blinding - Physiotherapist
Description
The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 2
Title
Blinding - Physiotherapist
Description
The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 6
Title
Blinding - Physiotherapist
Description
The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).
Time Frame
Week 12
Title
Retention
Description
The percentage of participants who remained in the study for the entire duration of their planned involvement.
Time Frame
Week 12
Title
Data completion
Description
The percentage of participants who complete all of the study questionnaires
Time Frame
Week 12
Title
Rate of Adverse events
Description
We will track adverse events the participants experience
Time Frame
Week 12
Secondary Outcome Measure Information:
Title
Pain - Visual Analog Scale
Description
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Time Frame
Week -2
Title
Pain - Visual Analog Scale
Description
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Time Frame
Week 0 - Immediately before injection
Title
Pain - Visual Analog Scale
Description
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Time Frame
Week 0 - Immediately after injection
Title
Pain - Visual Analog Scale
Description
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Time Frame
Week 2
Title
Pain - Visual Analog Scale
Description
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Time Frame
Week 6
Title
Pain - Visual Analog Scale
Description
We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant
Time Frame
Week 12
Title
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.
Time Frame
Week 12
Title
Pain - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Pain - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Pain - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Pain - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Pain - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 12
Title
Disease Severity - Complex Regional Pain Syndrome Severity Score
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Disease Severity - Complex Regional Pain Syndrome Severity Score
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Disease Severity - Complex Regional Pain Syndrome Severity Score
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Disease Severity - Complex Regional Pain Syndrome Severity Score
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Disease Severity - Complex Regional Pain Syndrome Severity Score
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.
Time Frame
Week 12
Title
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.
Time Frame
Week 12
Title
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Time Frame
Week -2
Title
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Time Frame
Week 0
Title
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Time Frame
Week 2
Title
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Time Frame
Week 6
Title
Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.
Time Frame
Week 12
Title
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.
Time Frame
Week 12
Title
Emotional and Psychological Function - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Emotional and Psychological Function - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Emotional and Psychological Function - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Emotional and Psychological Function - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Emotional and Psychological Function - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 12
Title
Quality of Life - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Quality of Life - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Quality of Life - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Quality of Life - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Quality of Life - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.
Time Frame
Week 12
Title
Total Score - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Time Frame
Week -2
Title
Total Score - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Time Frame
Week 0
Title
Total Score - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Time Frame
Week 2
Title
Total Score - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Time Frame
Week 6
Title
Total Score - EQ-5D-5L
Description
These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.
Time Frame
Week 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Able to provide signed and dated informed consent form Male or female, aged ≥18 years old Satisfy the Budapest Criteria for upper extremity CRPS A VAS score of at least 40 mm in the upper extremity to avoid flooring effect for injection-related pain reduction Exclusion Criteria: Uncontrolled hypertension (>180/110) Sepsis Bleeding diathesis Active cancer Brachial plexus injuries Neurological language deficits precluding participation Mini mental state examination score < 23 Acute mental illness (An acute mental illness is characterized by clinically significant symptoms of any metal health illness that requires immediate treatment. The physician making the recommendation to be part of the study. If the patient exhibits symptoms of any mental health illness that is not being treated by either the recommending physician or another member of the patient's care team the patient will not be recommended to participate in the study) Patients who are pregnant or breastfeeding
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Katherine Reilly, MSc
Phone
(613) 562 5800
Ext
8238
Email
kreilly@ohri.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mark Campbell, MD
Organizational Affiliation
Elisabeth Bruyere Hospital and The Ottawa Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Ottawa Hospital
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1H 8L6
Country
Canada
Facility Name
Elisabeth Bruyere Hospital
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1N5C8
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katherine Reilly, MSc
Phone
(613) 562 5800
Ext
8238
Email
kreilly@ohri.ca

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Peripheral Nerve Injections for CRPS

We'll reach out to this number within 24 hrs